🔎 Trials Near Me

Domov › Visok krvni tlak › Kalifornija

Klinične študije za Visok krvni tlak v Kalifornija

28 študij za Visok krvni tlak išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, San Jose
  • Retension Clinical Site, West Hills
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07142356

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  • Adventist Health Glendale, Glendale
  • Sutter Valley Hospitals, San Francisco
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06059638

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Thrive Clinical Research Group, Glendora
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • National Heart Institute, Beverly Hills
  • Hope Clinical Research, Canoga Park
  • John Muir Physician Network Clinical Research Center, Concord
  • in še 11
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Orange County Research Center, Lake Forest
  • Healthy Brain Clinic, Long Beach
  • Los Angeles Institute for Metabolic Research, Los Angeles
  • in še 6
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Beverly Hills
  • Research Site, Concord
  • Research Site, Fremont
  • in še 5
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • Cedar-Sinai Medical Center, Los Angeles
  • Stanford University, Palo Alto
Vključevanje udeležencev
Starost 22–75 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Beverly Hills
  • Clinical Trial Site, Chula Vista
  • Clinical Trial Site, Covina
  • in še 20
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07181109

A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

  • Clinical Trial Site, Lake Forest
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07553442

REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension

  • Kaiser Permanente Northern California, Oakland
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT07780500

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 0–20 · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT04278404

Secondhand Tobacco Smoke and Cardiovascular Disease

  • San Francisco Veterans' Affairs Medical Center, San Francisco
Vključevanje udeležencevFaza 4
Starost 40 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT04715568

Global Paradise System US Post Approval Study

  • Tibor Rubin VA Medical Center, Long Beach
  • Cedars-Sinai Medical Center, Los Angeles
  • Sutter Institute for Medical Research, Sacramento
  • in še 2
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06297291

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • University of California, Irvine
  • Antelope Valley Medical Center, Lancaster
  • Stanford Medical Center (Stanford Health Care), Palo Alto
Vključevanje udeležencevOpazovalna študija
Starost 18–100 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06402968

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • Clinical Trials Research, Lincoln
  • Downtown L A Research Center Inc, Los Angeles
  • Valley Clinical Trials, Northridge
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT07610278

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

  • NICRs Research Center, Garden Grove
  • Downtown L A Research Center Inc, Los Angeles
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT07543120

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

  • University of California, San Diego, La Jolla
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07725250

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

  • Bayview Research Group, Valley Village
  • Focus Clinical Research, West Hills
Vključevanje udeležencev
Starost 22 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT06843577

SPYRAL GEMINI Pilot Study

  • Stanford Hospital and Clinics, Stanford
Vključevanje udeležencev
Starost 18–80 · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT06907147

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

  • Wellth Inc., Los Angeles
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 16. mar. 2026 · NCT06876233

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Chula Vista
  • Vanda Investigative Site, Dublin
  • Vanda Investigative Site, Valencia
  • in še 1
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT07090161

Blood Pressure Care for Advancing Real-World Evidence (BPCARE)

  • Family Health Centers of San Diego, San Diego
Vključevanje udeležencev
Starost 21 in več · Vsi spoli · Posodobljeno 9. feb. 2026 · NCT07398391

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension

  • Loma Linda University Health, Loma Linda
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 4. feb. 2026 · NCT05551104

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

  • UCSF, San Francisco
Vključevanje udeležencevOpazovalna študija
Starost 18–100 · Vsi spoli · Posodobljeno 16. dec. 2025 · NCT06039176

Technology-enabled Management Versus Usual Care for Blood Pressure

  • Stanford Health Care, Palo Alto
Vključevanje udeležencev
Starost 30–90 · Vsi spoli · Posodobljeno 11. avg. 2025 · NCT05479461

Acupuncture Therapy and Hypertension

  • Susan Samueli Integrative Health Institute, Irvine
  • University of California, Irvine, Health Sciences Medical Center, Orange
Vključevanje udeležencev
Starost 45–75 · Vsi spoli · Posodobljeno 20. jul. 2025 · NCT05530512

Effect of Electro-Acupuncture on Blood Pressure

  • Susan Samueli Integrative Health Institute, Irvine
  • UCIMedical Center, Orange
Vključevanje udeležencev
Starost 18–85 · Vsi spoli · Posodobljeno 15. apr. 2025 · NCT00932139

Multi-Omics for Maternal Health After Preeclampsia

  • University of California, San Diego, San Diego
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–50 · Ženske · Posodobljeno 6. apr. 2025 · NCT06340152

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.